James J. McGough, MD, MS
Professor, Clinical Psychiatry
UCLA Semel Institute for Neuroscience and Human Behavior
Los Angeles, CA

Donald E. Greydanus, MD
Pediatrics Program Director
MSU/Kalamazoo Center for Medical Studies
Kalamazoo, MI
Professor, Pediatrics and Human Development
Michigan State University
East Lansing, MI

Gregory M. Asnis, MD
Professor of Psychiatry and Behavioral Sciences
Albert Einstein College of Medicine
Bronx, NY
Director, The Anxiety and Depression Program
Montefiore Medical Center,
Bronx, NY

After completing this activity, participants should be able to:

• Recognize the symptoms of ADHD and diagnose the disorder in older adolescents and adults.
• Select and titrate pharmacologic treatments that affect symptomatic behavior and improve the functioning of your patients with ADHD.
• Employ strategies to encourage patient adherence to treatment.

This activity has been independently reviewed for balance.

This continuing medical education activity is intended for psychiatrists, primary care physicians, and other healthcare professionals who seek to improve their care for patients with mental health disorders.

This activity is supported by an educational grant from

administered by Ortho-McNeil Janssen Scientific Affairs, LLC.

This activity will provide participants strategies and reinforcement in dose titration, multimodal treatment, and long-term treatment adherence for patients with ADHD.

Accreditation Statement

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Albert Einstein College of Medicine designates this educational activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Faculty Disclosures

Dr. McGough serves as a consultant and has received grant/research support from Eli Lilly and Company; and serves as a consultant for Shire Pharmaceuticals.

Dr. Greydanus has indicated that he has nothing to disclose.

Dr. Asnis serves on the speakers Bureau for sanofi aventis U.S.; and has also received grant/research support from GlaxoSmithKline, Lundbeck Inc., Pfizer Inc. and sanofi-aventis U.S.

Staff Disclosures

Steven Jay Feld, or a member of his household own securities in Bioheart, Inc., Chelsea Therapeutics, Inc. and Pharmacopeia, Inc.

Anne L. Finger and Regina Janesko have no disclosures to report. 

Conflict of Interest Statement

The "Conflict of Interest Disclosure Policy" of Albert Einstein College of Medicine requires that faculty participating in any CME activity disclose to the audience any relationship(s) with a pharmaceutical or equipment company.  Any presenter whose disclosed relationships prove to create a conflict of interest, with regard to their contribution to the activity, will not be permitted to present. 

The Albert Einstein College of Medicine also requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product, or device, not yet approved for use in the United States.

The staff of CCME of Albert Einstein College of Medicine and Veritas Institute for Medical Education, Inc. have no conflicts of interests to report with commercial interests related directly or indirectly to this educational activity.

Disclaimer

The opinions and recommendations expressed by faculty and other experts whose input is included in this activity are their own and do not necessarily reflect the views of the sponsors or supporter. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the faculty or may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Activity participants are encouraged to refer to primary references or full prescribing information resources.

Method of Participation

Participants are required to review the entire presentation and to complete the posttest and evaluation to earn a certificate of completion.

This enduring activity is a spin-off of a live presentation at the 2009 U.S. Psychiatric and Mental Health Congress, November 3, 2009, in Las Vegas, NV. If you have earned a certificate for the live session, you are ineligible to earn a certificate for the enduring spin-off.

Estimated Time to Complete

The activity in its entirety should take approximately 120 minutes to complete.